Animal models for osteoporosis.

The major types of osteoporosis in humans are postmenopausal osteoporosis, disuse osteoporosis, and glucocorticoid-induced osteoporosis. Animal models for postmenopausal osteoporosis are generated by ovariectomy. Bone loss occurs in estrogen deficiency due to enhanced bone resorption and impaired osteoblast function. Estrogen receptor α induces osteoclast apoptosis, but the mechanism for impaired osteoblast function remains to be clarified. Animal models for unloading are generated by tail suspension or hind limb immobilization by sciatic neurectomy, tenotomy, or using plaster cast. Unloading inhibits bone formation and enhances bone resorption, and the involvement of the sympathetic nervous system in it needs to be further investigated. The osteocyte network regulates bone mass by responding to mechanical stress. Osteoblast-specific BCL2 transgenic mice, in which the osteocyte network is completely disrupted, can be a mouse model for the evaluation of osteocyte functions. Glucocorticoid treatment inhibits bone formation and enhances bone resorption, and markedly reduces cancellous bone in humans and large animals, but not consistently in rodents.

[1]  M. Almeida,et al.  Estrogen receptor-α signaling in osteoblast progenitors stimulates cortical bone accrual. , 2013, The Journal of clinical investigation.

[2]  H. Woitge,et al.  Expression and activity of osteoblast-targeted Cre recombinase transgenes in murine skeletal tissues. , 2004, The International journal of developmental biology.

[3]  T. Wronski,et al.  Skeletal response to corticosteroid deficiency and excess in growing male rats. , 1996, Bone.

[4]  A. Parfitt,et al.  Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone. , 1998, The Journal of clinical investigation.

[5]  C. Christiansen,et al.  Estrogens, bone loss and preservation , 1990, Osteoporosis International.

[6]  K Yano,et al.  Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[7]  T. Martin,et al.  Wnt5a-Ror2 signaling between osteoblast-lineage cells and osteoclast precursors enhances osteoclastogenesis , 2012, Nature Medicine.

[8]  J. Nyman,et al.  Extracellular Norepinephrine Clearance by the Norepinephrine Transporter Is Required for Skeletal Homeostasis* , 2013, The Journal of Biological Chemistry.

[9]  P. Marie,et al.  S12911-2 reduces bone loss induced by short-term immobilization in rats. , 2003, Bone.

[10]  K. Dahlman-Wright,et al.  Estrogen receptor-α in osteocytes is important for trabecular bone formation in male mice , 2013, Proceedings of the National Academy of Sciences.

[11]  Mary L Bouxsein,et al.  Deletion of β‐adrenergic receptor 1, 2, or both leads to different bone phenotypes and response to mechanical stimulation , 2012, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[12]  A. Zallone,et al.  FSH Directly Regulates Bone Mass , 2006, Cell.

[13]  K. Korach,et al.  Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. , 1994, The New England journal of medicine.

[14]  S. Morony,et al.  OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis , 1999, Nature.

[15]  T. Wronski,et al.  Skeletal abnormalities in rats induced by simulated weightlessness. , 1982, Metabolic bone disease & related research.

[16]  T. Komori Functions of the osteocyte network in the regulation of bone mass , 2013, Cell and Tissue Research.

[17]  Mark L. Johnson,et al.  Connexin 43 Channels Are Essential for Normal Bone Structure and Osteocyte Viability , 2015, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[18]  J. Vacher,et al.  Targeted expression of Cre recombinase in macrophages and osteoclasts in transgenic mice , 2005, Genesis.

[19]  L. Bonewald,et al.  Estrogen receptor α in osteocytes regulates trabecular bone formation in female mice. , 2014, Bone.

[20]  E. Hesse,et al.  Double disruption of α2A‐ and α2C ‐adrenoceptors results in sympathetic hyperactivity and high‐bone‐mass phenotype , 2011, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[21]  H. Broxmeyer,et al.  Increased osteoclast development after estrogen loss: mediation by interleukin-6 , 1992 .

[22]  B. Riggs,et al.  Glucocorticoid regulation of insulin-like growth factor-binding protein expression in normal human osteoblast-like cells. , 1994, Endocrinology.

[23]  R. Fukuyama,et al.  Overexpression of Bcl2 in Osteoblasts Inhibits Osteoblast Differentiation and Induces Osteocyte Apoptosis , 2011, PloS one.

[24]  R. Capozza,et al.  Biphasic dose-response curves of cortisol effects on rat diaphyseal bone biomechanics , 2004, Calcified Tissue International.

[25]  Dong Hoon Lee,et al.  Chronic immobilization stress induces anxiety- and depression-like behaviors and decreases transthyretin in the mouse cortex , 2009, Neuroscience Letters.

[26]  L. Quarles,et al.  Prednisone-induced osteopenia in beagles: variable effects mediated by differential suppression of bone formation. , 1992, The American journal of physiology.

[27]  J. David,et al.  Glucocorticoids suppress bone formation by attenuating osteoblast differentiation via the monomeric glucocorticoid receptor. , 2010, Cell metabolism.

[28]  C. King,et al.  Effects of continuous glucocorticoid infusion on bone metabolism in the rat , 1996, Calcified Tissue International.

[29]  S. Manolagas,et al.  Transduction of Cell Survival Signals by Connexin-43 Hemichannels* , 2002, The Journal of Biological Chemistry.

[30]  L. S. Stern,et al.  Effects of aminohydroxybutane bisphosphonate on bone growth when administered after hind-limb bone loss in tail-suspended rats. , 1993, The Journal of pharmacology and experimental therapeutics.

[31]  Chen Bei,et al.  Characterization of a rabbit osteoporosis model induced by ovariectomy and glucocorticoid , 2010, Acta orthopaedica.

[32]  L. Vico,et al.  Bone histomorphometric comparison of rat tibial metaphysis after 7-day tail suspension vs. 7-day spaceflight. , 1991, Aviation, space, and environmental medicine.

[33]  S. Goldfarb,et al.  WR‐2721 reduces bone loss after hindlimb tenotomy in rats , 1989, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[34]  S. Doty,et al.  Alendronate increases skeletal mass of growing rats during unloading by inhibiting resorption of calcified cartilage , 1994, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[35]  M. Bouxsein,et al.  Mice lacking beta-adrenergic receptors have increased bone mass but are not protected from deleterious skeletal effects of ovariectomy. , 2009, Endocrinology.

[36]  K. Jones,et al.  Inhibition by prednisone of growth hormone (GH) response to GH-releasing hormone in normal men. , 1988, The Journal of clinical endocrinology and metabolism.

[37]  Kevin J. Tracey,et al.  High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal , 2005, Nature Reviews Immunology.

[38]  P. Geusens,et al.  Effect of ovariectomy and prednisolone on bone mineral content in rats: Evaluation by single photon absorptiometry and radiogrammetry , 1990, Calcified Tissue International.

[39]  E R Morey,et al.  Inhibition of bone formation during space flight. , 1978, Science.

[40]  D. Bikle,et al.  Glucocorticoids and inhibition of bone formation induced by skeletal unloading. , 1988, The American journal of physiology.

[41]  T. Wronski,et al.  Time course of vertebral osteopenia in ovariectomized rats. , 1989, Bone.

[42]  R. Globus,et al.  The temporal response of bone to unloading. , 1986, Endocrinology.

[43]  C. Chenu,et al.  Blockade of beta-adrenergic signaling does not influence the bone mechano-adaptive response in mice. , 2007, Bone.

[44]  M. Almeida,et al.  The estrogen receptor-alpha in osteoclasts mediates the protective effects of estrogens on cancellous but not cortical bone. , 2010, Molecular endocrinology.

[45]  P. Geusens,et al.  Effect of 1α-vitamin D3 on bone strength and composition in growing rats with and without corticosteroid treatment , 1994, Calcified Tissue International.

[46]  F. Lavaste,et al.  Effects of glucocorticoids on skeletal growth in rabbits evaluated by dual-photon absorptiometry, microscopic connectivity and vertebral compressive strength , 1994, Osteoporosis International.

[47]  Masaki Noda,et al.  Unloading Induces Osteoblastic Cell Suppression and Osteoclastic Cell Activation to Lead to Bone Loss via Sympathetic Nervous System* , 2005, Journal of Biological Chemistry.

[48]  R. Fukuyama,et al.  Osteocyte Network; a Negative Regulatory System for Bone Mass Augmented by the Induction of Rankl in Osteoblasts and Sost in Osteocytes at Unloading , 2012, PloS one.

[49]  M. Poutanen,et al.  Inactivation of estrogen receptor α in bone‐forming cells induces bone loss in female mice , 2013, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[50]  E. Canalis,et al.  Cortisol inhibits the synthesis of insulin-like growth factor-I in skeletal cells. , 1990, Endocrinology.

[51]  C. Marcelli,et al.  Sympathetic nervous system as transmitter of mechanical loading in bone. , 2003, Joint, bone, spine : revue du rhumatisme.

[52]  Yiping Shen,et al.  Delayed puberty and estrogen resistance in a woman with estrogen receptor α variant. , 2013, The New England journal of medicine.

[53]  Jennifer Y. Zhang,et al.  BCL2 inhibits Cell Adhesion, Spreading, and Motility by Enhancing Actin Polymerization , 2010, Cell Research.

[54]  Minqi Li,et al.  Targeted ablation of osteocytes induces osteoporosis with defective mechanotransduction. , 2007, Cell metabolism.

[55]  Y. Tanaka,et al.  Bone marrow capacity for bone cells and trabecular bone turnover in immobilized tibia after sciatic neurectomy in mice. , 1996, Bone.

[56]  H. Oxlund,et al.  Growth Hormone Increases Cortical and Cancellous Bone Mass in Young Growing Rats with Glucocorticoid‐Induced Osteopenia , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[57]  L. Donahue,et al.  Cortical tibial bone volume in two strains of mice: effects of sciatic neurectomy and genetic regulation of bone response to mechanical loading. , 1999, Bone.

[58]  Masaki Noda,et al.  Leptin regulation of bone resorption by the sympathetic nervous system and CART , 2005, Nature.

[59]  Laurence Vico,et al.  Tail Suspension Induces Bone Loss in Skeletally Mature Mice in the C57BL/6J Strain but Not in the C3H/HeJ Strain , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[60]  A. Sakai,et al.  Changes in trabecular bone turnover and bone marrow cell development in tail-suspended mice. , 2001, Journal of musculoskeletal & neuronal interactions.

[61]  N. Binkley,et al.  Zoledronate Prevents the Development of Absolute Osteopenia Following Ovariectomy in Adult Rhesus Monkeys , 1998, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[62]  R. Main,et al.  Female Mice Lacking Estrogen Receptor‐Alpha in Osteoblasts Have Compromised Bone Mass and Strength , 2014, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[63]  T. Wronski,et al.  Time course of femoral neck osteopenia in ovariectomized rats. , 1996, Bone.

[64]  Z. Hochberg,et al.  Interactions between growth hormone and dexamethasone in skeletal growth and bone structure of the young mouse , 1992, Calcified Tissue International.

[65]  A. Leblanc,et al.  Skeletal responses to space flight and the bed rest analog: a review. , 2007, Journal of musculoskeletal & neuronal interactions.

[66]  Hiroshi Ohshima,et al.  Intravenous Pamidronate Prevents Femoral Bone Loss and Renal Stone Formation During 90‐Day Bed Rest , 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[67]  T. Komori Signaling networks in RUNX2‐dependent bone development , 2011, Journal of cellular biochemistry.

[68]  Toshitaka Nakamura,et al.  Trabecular Bone Turnover and Bone Marrow Cell Development in Tail‐Suspended Mice , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[69]  M W Luttges,et al.  Contribution of dietary and loading changes to the effects of suspension on mouse femora. , 1994, The Journal of experimental zoology.

[70]  Stefan Judex,et al.  Genetically Linked Site‐Specificity of Disuse Osteoporosis , 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[71]  A. Turner,et al.  The sheep as a model for osteoporosis in humans. , 2002, Veterinary journal.

[72]  M. Ding,et al.  Glucocorticoid Induced Osteopenia in Cancellous Bone of Sheep: Validation of Large Animal Model for Spine Fusion and Biomaterial Research , 2010, Spine.

[73]  E. Olson,et al.  Conditional inactivation of FGF receptor 2 reveals an essential role for FGF signaling in the regulation of osteoblast function and bone growth , 2003, Development.

[74]  P. Garnero,et al.  Short-term effects of corticosteroids on trabecular bone remodeling in old ewes. , 1997, Bone.

[75]  T. Wronski,et al.  Temporal relationship between bone loss and increased bone turnover in ovariectomized rats , 1988, Calcified Tissue International.

[76]  W. Zong,et al.  Necrotic death as a cell fate. , 2006, Genes & development.

[77]  C. Turner,et al.  Skeletal health: primate model of postmenopausal osteoporosis , 2009, American journal of primatology.

[78]  G. Rodan,et al.  Osteopenia in the immobilized rat hind limb is associated with increased bone resorption and decreased bone formation. , 1989, Bone.

[79]  R. Turner,et al.  Prednisone inhibits formation of cortical bone in sham-operated and ovariectomized female rats , 1995, Calcified Tissue International.

[80]  Sundeep Khosla,et al.  Population‐Based Study of Age and Sex Differences in Bone Volumetric Density, Size, Geometry, and Structure at Different Skeletal Sites , 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[81]  L. Cui,et al.  Glucocorticoid-Induced Osteoporosis in Growing Rats , 2014, Calcified Tissue International.

[82]  Toshihisa Komori,et al.  Regulation of bone development and extracellular matrix protein genes by RUNX2 , 2009, Cell and Tissue Research.

[83]  Richard A Robb,et al.  A Population‐Based Assessment of Rates of Bone Loss at Multiple Skeletal Sites: Evidence for Substantial Trabecular Bone Loss in Young Adult Women and Men , 2007, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[84]  P. Chambon,et al.  Estrogen Prevents Bone Loss via Estrogen Receptor α and Induction of Fas Ligand in Osteoclasts , 2007, Cell.

[85]  C. O’Brien Control of RANKL gene expression. , 2010, Bone.

[86]  G. Passeri,et al.  Cell autonomous requirement of connexin 43 for osteocyte survival: Consequences for endocortical resorption and periosteal bone formation , 2012, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[87]  C. Yallampalli,et al.  Prevention of corticosteroid-induced bone loss with nitric oxide donor nitroglycerin in male rats. , 1997, Bone.

[88]  L. Mosekilde,et al.  Cortical bone mass, composition, and mechanical properties in female rats in relation to age, long-term ovariectomy, and estrogen substitution , 2004, Calcified Tissue International.

[89]  P. Delmas,et al.  Effects of a New Selective Estrogen Receptor Modulator (MDL 103,323) on Cancellous and Cortical Bone in Ovariectomized Ewes: A Biochemical, Histomorphometric, and Densitometric Study , 2001, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[90]  S. Pollack,et al.  Treatment of denervation/disuse osteoporosis in the rat with a capacitively coupled electrical signal: Effects on bone formation and bone resorption , 1988, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[91]  A. Cassady,et al.  Transgenic mice that express Cre recombinase in osteoclasts , 2004, Genesis.

[92]  J. Bilezikian,et al.  Glucocorticoid-induced osteoporosis: pathophysiology and therapy , 2007, Osteoporosis International.

[93]  R. Pacifici Estrogen deficiency, T cells and bone loss. , 2008, Cellular immunology.